Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome

Conditions:   Breast Cancer;   Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms;   Neuroblastoma;   Ovarian Cancer;   Testicular Germ Cell TumorIntervention:   Dietary Supplement: Lactobacillus rhamnosus GGSponsors:   Rutgers, The State University of New Jersey;   National Cancer Institute (NCI);   Rutgers Cancer Institute of New JerseyActive, not recruiting - verified March 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials